Hi ,
I am 28 years old below mention my lab result .is there any risk ?
WBC
5.2
4.0-10.0
giga/L
RBC
4.47
3.80-4.80
tera/L
Hemoglobin
131
120-150
g/L
Hematocrit
0.39
0.35-0.43
MCV
87
82-98
fl
MCH
29.3
27.5-33.5
pg
MCHC
339
305-365
g/L
RDW
12.6
11.5-14.5
%
Platelet Count
335
150-400
giga/L
Differential
Neutrophils
3.5
2.0-7.5
giga/L
Lymphocytes
1.3
1.0-4.0
giga/L
Monocytes
0.4
0.1-0.8
giga/L
Eosinophils
0.1
0.0-0.7
giga/L
Basophils
0.0
0.0-0.2
giga/L
Granulocytes Immature
0.0
<0.2
giga/L
Biochemical Investigation of Anemias and Iron Overload
Ferritin
35
15-180
ug/L
     Adults: <15: diagnostic of Iron Deficiency
15-50: Probable Iron Deficiency
51-100: Possible Iron Deficiency
>100: Iron Deficiency unlikely
persistently >1000: Test for Iron overload

Children: <12: diagnosis of Iron Deficiency
http:/www.bcguidelines.ca/guideline_iron_
deficiency.html
Urinalysis
Urine Chemistry
Colour
YELLOW
Appearance
CLEAR
pH
7.5
5.0-8.5
Specific Gravity
1.008
1.003-1.035
Protein
<0.3
<0.3
g/L
Glucose
<6
<6
mmol/L
Ketones
<1.5
<1.5
mmol/L
Hemoglobin
NEG
Neg
Nitrite
NEG
Neg
Leukocytes
NEG
Neg

General Chemistry
Sodium
140
134-145
mmol/L
Potassium
4.2
3.5-5.0
mmol/L
Creatinine
A
43
50-100
umol/L
Estimated GFR
>120
>=60
mL/min
     As of December 15, 2014, eGFR will be
calculated by the CKD-EPI formula. Shown
to improve accuracy in older patients,
approximately 2% of patients will be re-
classified.

Kidney function estimate based on
assumption of a stable serum creatinine
concentration: diet, drugs, pregnancy,
clinical state and muscle mass can affect
accuracy of the estimate. Urinary ACR may
assist interpretation.
See www.bcguidelines.ca/pdf/ckd.pdf
Gamma GT
11
<59
U/L
ALT
10
<50
U/L
Thyroid Function
TSH
A
0.02
0.27-4.2
mU/L
Pituitary Function
Prolactin
16.1
<25
ug/L
Reproductive and Gonadal
Androstenedione
3.9
nmol/L
     Pre-menopausal: 0.91 - 7.47 nmol/L
Post-menopausal: 0.45 - 2.86 nmol/L
17OH Progesterone
2.5
nmol/L
     New method (LC/MS) effective November 13,
2014: results typically 70% lower than
previous radioimmunoassay. Reference
intervals have been adjusted and are
consistent with BC Women & Children's
Hospital method.
Follicular Phase <2.4 nmol/L
Luteal Phase <8.6 nmol/L
Post-Menopausal <1.5 nmol/L
Normal 17-Hydroxyprogesterone does not
rule out congenital adrenal hyperplasia
or adrenal or ovarian pathology.
DHEA Sulphate
7.5
<10.8
umol/L
Testosterone
1.3
<1.8
nmol/L
Serum Proteins
C Reactive Protein (High Sensitivity)
0.6
<5.0
mg/L
     High-sensitivity method suitable for
cardiovascular risk assessment.
Immunology
Nuclear Ab Titre and Pattern
Neg
Titre <1:80
     
Note: new method as of July 6, 2015.
For more information, see Healthcare
Provider News & Notices BC at
www.LifeLabs.com

HEp-2000 cell substrate for indirect
immunofluorescence
shows improved sen-
sensitivity for SS-A/Ro antibodies.

Antinuclear antibodies (ANAs) are
commonly detected in the sera of patients
with systemic autoimmune rheumatic dis-
eases. Specimen was screened at 1:80
titre. A negative test rarely needs to be
repeated unless there is a strong clini-
cal suspicion of evolving disease or a
clinical change suggesting diagnostic
review.

Rheumatoid Factor
<14
kU/L
     <14 kU/L = Negative
14-30 kU/L = Indeterminate
>30 kU/L = Positive
Thyroid Function
TSH
A
0.01
0.27-4.2
mU/L
T4 Free
A
26.2
10.5-20.0
pmol/L
     The free T3 order was cancelled. The
BCMA/MSP Protocol recommends no further
testing. However, a specimen will be
stored seven days.
Thyroperoxidase Ab     Results are pending ...
Serum Proteins
C Reactive Protein (High Sensitivity)
1.1
<5.0
mg/L
     High-sensitivity method suitable for
cardiovascular risk assessment.